The human body has the capacity to produce an array of specialized T cells, which provide unique responses to a diverse range of tumour cells and pathogens. The modulation of T cells is an exciting prospect for the development of novel therapies for immuno-oncology –autoimmune applications, adoptive cell therapy and vaccine development. Download here

- Home
- News
- DDW Exclusive Content
- Opinion
- Business
- Regulatory
- Intelligence
Categories
Latest Industry Intelligence
- Cancer Research
- Webinars
- Podcasts
- Archive
- Videos